Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SZSE:300760.SZ
256.8 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 36,725.75 | 34,931.901 | 30,365.644 | 25,269.581 | 21,025.846 | 16,555.991 | 13,753.357 | 11,173.795 | 9,031.723 | 8,013.11 | 7,835.718 |
| Cost of Revenue
| 13,547.519 | 12,513.136 | 10,885.289 | 8,842.715 | 7,366.094 | 5,755.057 | 4,597.398 | 3,684.012 | 3,195.252 | 3,027.702 | 2,865.658 |
| Gross Profit
| 23,178.23 | 22,418.765 | 19,480.354 | 16,426.866 | 13,659.752 | 10,800.934 | 9,155.959 | 7,489.784 | 5,836.471 | 4,985.408 | 4,970.06 |
| Gross Profit Ratio
| 0.631 | 0.642 | 0.642 | 0.65 | 0.65 | 0.652 | 0.666 | 0.67 | 0.646 | 0.622 | 0.634 |
| Reseach & Development Expenses
| 3,665.861 | 3,432.659 | 2,922.614 | 2,524.178 | 1,869.3 | 1,465.611 | 1,267.159 | 1,018.112 | 989.666 | 988.227 | 944.069 |
| General & Administrative Expenses
| 468.262 | 452.5 | 361.944 | 339.858 | 284.086 | 228.528 | 211.612 | 152.34 | 319.875 | 327.194 | 1,685.59 |
| Selling & Marketing Expenses
| 1,253.484 | 5,702.924 | 4,801.555 | 3,998.948 | 3,611.687 | 3,605.667 | 3,202.234 | 2,726.864 | 2,400.934 | 2,175.827 | 2,085.355 |
| SG&A
| 1,721.746 | 6,155.424 | 5,163.499 | 4,338.806 | 3,895.773 | 3,834.196 | 3,413.845 | 2,879.204 | 2,720.808 | 2,503.021 | 3,770.946 |
| Other Expenses
| 4,678.8 | -1,117.165 | 726.579 | 472.974 | 354.467 | 363.215 | 99.131 | 51.782 | 302.613 | 128.106 | 248.538 |
| Operating Expenses
| 10,066.406 | 10,041.335 | 8,812.693 | 7,335.958 | 6,119.539 | 5,663.022 | 4,979.64 | 4,212.589 | 4,314.782 | 4,012.353 | 3,846.73 |
| Operating Income
| 13,111.824 | 13,069.858 | 10,990.515 | 9,065.717 | 7,455.16 | 5,378.792 | 4,278.156 | 2,879.586 | 1,548.943 | 961.396 | 1,207.531 |
| Operating Income Ratio
| 0.357 | 0.374 | 0.362 | 0.359 | 0.355 | 0.325 | 0.311 | 0.258 | 0.172 | 0.12 | 0.154 |
| Total Other Income Expenses Net
| -92.128 | -58.928 | -36.964 | -48.632 | -16.72 | -10.539 | -39.831 | 51.782 | 302.613 | 128.106 | 248.538 |
| Income Before Tax
| 13,019.696 | 13,010.93 | 10,953.551 | 9,017.085 | 7,438.44 | 5,368.254 | 4,238.325 | 2,931.367 | 1,851.556 | 1,089.502 | 1,456.068 |
| Income Before Tax Ratio
| 0.355 | 0.372 | 0.361 | 0.357 | 0.354 | 0.324 | 0.308 | 0.262 | 0.205 | 0.136 | 0.186 |
| Income Tax Expense
| 1,279.73 | 1,432.517 | 1,342.834 | 1,013.039 | 778.837 | 683.437 | 512.583 | 330.176 | 239.372 | 148.998 | 61.277 |
| Net Income
| 11,668.487 | 11,582.226 | 9,607.174 | 8,001.554 | 6,657.676 | 4,680.647 | 3,719.236 | 2,589.155 | 1,600.457 | 909.88 | 1,359.671 |
| Net Income Ratio
| 0.318 | 0.332 | 0.316 | 0.317 | 0.317 | 0.283 | 0.27 | 0.232 | 0.177 | 0.114 | 0.174 |
| EPS
| 9.64 | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 | 2.37 | 1.61 | 0.98 | 1.47 |
| EPS Diluted
| 9.63 | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | 3.34 | 2.37 | 1.61 | 0.98 | 1.47 |
| EBITDA
| 14,489.076 | 14,145.818 | 11,948.446 | 9,827.021 | 7,996.867 | 5,853.392 | 4,700.426 | 3,261.906 | 2,129.22 | 1,444.798 | 1,123.33 |
| EBITDA Ratio
| 0.395 | 0.405 | 0.393 | 0.389 | 0.38 | 0.354 | 0.342 | 0.292 | 0.236 | 0.18 | 0.143 |